---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290862953.md"
description: "During Thursday's intraday session, several healthcare stocks experienced significant volatility. Atlantic International surged 41% to $1.1, while SELLAS Life Sciences and Bio-Techne rose over 20%. Conversely, Nano X Imaging plummeted 49.6% to $0.79 following Q1 earnings, with Passage Bio and ENDRA Life Sciences also posting sharp declines of 38% and 35% respectively."
datetime: "2026-06-25T17:05:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290862953.md)
  - [en](https://longbridge.com/en/news/290862953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290862953.md)
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Atlantic International** (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday's regular session. The company's market cap stands at $59.4 million. As per the press release, Q1 earnings came out 3 days ago.
-   **SELLAS Life Sciences Gr** (NASDAQ:SLS) stock rose 20.01% to $11.01. The company's market cap stands at $1.8 billion.
-   **Bio-Techne** (NASDAQ:TECH) shares rose 19.81% to $70.54. The company's market cap stands at $9.1 billion.
-   **Helus Pharma** (NASDAQ:HELP) stock moved upwards by 18.27% to $6.02. The company's market cap stands at $253.9 million.
-   **Nurix Therapeutics** (NASDAQ:NRIX) stock increased by 17.3% to $22.64. The market value of their outstanding shares is at $1.9 billion.
-   **Oramed Pharmaceuticals** (NASDAQ:ORMP) shares moved upwards by 16.99% to $5.03. The company's market cap stands at $175.9 million.

### Losers

-   **Nano X Imaging** (NASDAQ:NNOX) stock fell 49.6% to $0.79 during Thursday's regular session. The market value of their outstanding shares is at $91.8 million. As per the press release, Q1 earnings came out today.
-   **Passage Bio** (NASDAQ:PASG) stock declined by 38.27% to $3.63. The market value of their outstanding shares is at $18.8 million.
-   **ENDRA Life Sciences** (NASDAQ:NDRA) shares decreased by 35.73% to $4.03. The company's market cap stands at $11.5 million.
-   **Curis** (NASDAQ:CRIS) stock fell 32.6% to $0.23. The market value of their outstanding shares is at $13.2 million.
-   **CDT Equity** (NASDAQ:CDT) stock declined by 32.12% to $0.74. The company's market cap stands at $5.2 million.
-   **ARS Pharmaceuticals** (NASDAQ:SPRY) stock fell 26.0% to $7.8. The market value of their outstanding shares is at $1.0 billion. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [NNOX.US](https://longbridge.com/en/quote/NNOX.US.md)
- [ATLN.US](https://longbridge.com/en/quote/ATLN.US.md)
- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)
- [SLS.US](https://longbridge.com/en/quote/SLS.US.md)
- [PASG.US](https://longbridge.com/en/quote/PASG.US.md)
- [NDRA.US](https://longbridge.com/en/quote/NDRA.US.md)
- [CIRC.US](https://longbridge.com/en/quote/CIRC.US.md)
- [HELP.US](https://longbridge.com/en/quote/HELP.US.md)
- [NRIX.US](https://longbridge.com/en/quote/NRIX.US.md)
- [ORMP.US](https://longbridge.com/en/quote/ORMP.US.md)
- [CRIS.US](https://longbridge.com/en/quote/CRIS.US.md)
- [CDT.US](https://longbridge.com/en/quote/CDT.US.md)
- [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md)
- [SQLLW.US](https://longbridge.com/en/quote/SQLLW.US.md)
- [CYBN.US](https://longbridge.com/en/quote/CYBN.US.md)
- [29273B500.US](https://longbridge.com/en/quote/29273B500.US.md)
- [CDTTW.US](https://longbridge.com/en/quote/CDTTW.US.md)

## Related News & Research

- [Is SELLAS Life Sciences Group (SLS) Fully Priced As Regal Trial Debate Heats Up?](https://longbridge.com/en/news/293684135.md)
- [Nano-X CEO Erez Meltzer buys 36,000 shares for USD 33,480](https://longbridge.com/en/news/294113206.md)
- [Dan Suesskind Purchases 50,000 Shares of Nano-X Imaging (NASDAQ:NNOX) Stock](https://longbridge.com/en/news/294213303.md)
- [Nanox Issues Preliminary Q2 2026 Results as Cash Crunch Raises Going-Concern Doubts](https://longbridge.com/en/news/293673280.md)
- [Nano-X Imaging files for $53.9 million remaining under at-the-market share offering](https://longbridge.com/en/news/293670696.md)